Max Healthcare Institute Limited

BSE:543220 Stock Report

Market Cap: ₹971.9b

Max Healthcare Institute Valuation

Is 543220 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543220 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 543220 (₹999.8) is trading above our estimate of fair value (₹456.89)

Significantly Below Fair Value: 543220 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543220?

Key metric: As 543220 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 543220. This is calculated by dividing 543220's market cap by their current earnings.
What is 543220's PE Ratio?
PE Ratio91.8x
Earnings₹10.59b
Market Cap₹971.94b

Price to Earnings Ratio vs Peers

How does 543220's PE Ratio compare to its peers?

The above table shows the PE ratio for 543220 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average67x
APOLLOHOSP Apollo Hospitals Enterprise
84x30.7%₹997.2b
FORTIS Fortis Healthcare
79x26.8%₹517.8b
NH Narayana Hrudayalaya
33.2x13.6%₹258.4b
KIMS Krishna Institute of Medical Sciences
71.9x24.3%₹238.2b
543220 Max Healthcare Institute
91.8x30.8%₹971.9b

Price-To-Earnings vs Peers: 543220 is expensive based on its Price-To-Earnings Ratio (91.8x) compared to the peer average (67x).

Price to Earnings Ratio vs Industry

How does 543220's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.76m
542918 Gian Life Care
4.9xn/aUS$2.33m
No more companies available in this PE range
543220 91.8xIndustry Avg. 41.9xNo. of Companies5PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 543220 is expensive based on its Price-To-Earnings Ratio (91.8x) compared to the Indian Healthcare industry average (41.9x).

Price to Earnings Ratio vs Fair Ratio

What is 543220's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543220 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio91.8x
Fair PE Ratio90.9x

Price-To-Earnings vs Fair Ratio: 543220 is expensive based on its Price-To-Earnings Ratio (91.8x) compared to the estimated Fair Price-To-Earnings Ratio (90.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 543220 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹999.80
₹1,084.75
+8.5%
14.3%₹1,250.00₹615.00n/a20
Nov ’25₹1,006.75
₹940.05
-6.6%
13.6%₹1,238.00₹560.00n/a19
Oct ’25₹969.00
₹938.32
-3.2%
13.8%₹1,240.00₹560.00n/a19
Sep ’25₹864.25
₹922.00
+6.7%
12.1%₹1,060.00₹560.00n/a19
Aug ’25₹924.25
₹872.78
-5.6%
11.8%₹1,060.00₹560.00n/a18
Jul ’25₹955.05
₹860.33
-9.9%
10.8%₹950.00₹560.00n/a18
Jun ’25₹752.20
₹855.06
+13.7%
13.0%₹950.00₹465.00n/a18
May ’25₹839.20
₹844.24
+0.6%
13.9%₹950.00₹465.00n/a17
Apr ’25₹814.55
₹832.31
+2.2%
14.3%₹940.00₹465.00n/a16
Mar ’25₹736.40
₹827.13
+12.3%
14.6%₹940.00₹465.00n/a15
Feb ’25₹801.80
₹738.31
-7.9%
16.4%₹925.00₹465.00n/a16
Jan ’25₹688.25
₹657.40
-4.5%
10.8%₹780.00₹465.00n/a15
Dec ’24₹652.00
₹644.73
-1.1%
9.7%₹730.00₹465.00n/a15
Nov ’24₹576.40
₹612.08
+6.2%
8.3%₹670.00₹465.00₹1,006.7513
Oct ’24₹567.35
₹614.00
+8.2%
8.3%₹670.00₹465.00₹969.0013
Sep ’24₹575.25
₹611.69
+6.3%
8.8%₹670.00₹465.00₹864.2513
Aug ’24₹571.80
₹570.64
-0.2%
10.1%₹660.00₹465.00₹924.2511
Jul ’24₹599.25
₹574.73
-4.1%
7.1%₹642.00₹490.00₹955.0511
Jun ’24₹532.15
₹563.60
+5.9%
5.8%₹600.00₹490.00₹752.2010
May ’24₹459.05
₹521.50
+13.6%
5.2%₹570.00₹490.00₹839.2010
Apr ’24₹441.00
₹515.63
+16.9%
4.9%₹570.00₹490.00₹814.558
Mar ’24₹433.25
₹515.63
+19.0%
4.9%₹570.00₹490.00₹736.408
Feb ’24₹441.40
₹513.75
+16.4%
4.8%₹570.00₹490.00₹801.808
Jan ’24₹438.95
₹511.88
+16.6%
4.9%₹570.00₹490.00₹688.258
Dec ’23₹452.30
₹511.88
+13.2%
4.9%₹570.00₹490.00₹652.008
Nov ’23₹457.35
₹463.38
+1.3%
5.1%₹490.00₹425.00₹576.408

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Medico Intercontinental

₹592.5m

Trades in pharmaceutical products.

539938

₹59.25

7D

28.6%

1Y

-37.0%

N G Industries

₹547.0m

Provides various healthcare services in India.

530897

₹163.25

7D

-2.7%

1Y

-2.5%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

7D

0%

1Y

n/a